139 related articles for article (PubMed ID: 7379313)
1. Size reduction of a prolactin secreting adenoma during long-term treatment with the dopamine agonist lisuride.
Chiodini PG; Liuzzi A; Verde G; Cozzi R; Silvestrini F; Marsili MT; Horowski R; Passerini F; Luccarelli G; Borghi PG
Clin Endocrinol (Oxf); 1980 Jan; 12(1):47-51. PubMed ID: 7379313
[TBL] [Abstract][Full Text] [Related]
2. Rapid regression of macroprolactinomas by the new dopamine partial agonist terguride.
Gräf KJ; Köhler D; Horowski R; Dorow R
Acta Endocrinol (Copenh); 1986 Apr; 111(4):460-6. PubMed ID: 3085417
[TBL] [Abstract][Full Text] [Related]
3. Low doses of dopamine agonists in the long-term treatment of macroprolactinomas.
Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG; Cozzi R; Chiodini P; Luccarelli G
N Engl J Med; 1985 Sep; 313(11):656-9. PubMed ID: 4022058
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
Goodman LA; Chang RJ
Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic treatment of acromegaly: different effects on hormone secretion and tumor size.
Oppizzi G; Liuzzi A; Chiodini P; Dallabonzana D; Spelta B; Silvestrini F; Borghi G; Tonon C
J Clin Endocrinol Metab; 1984 Jun; 58(6):988-92. PubMed ID: 6725515
[TBL] [Abstract][Full Text] [Related]
6. [Lisuride in the treatment of hyperfunctioning hypophyseal adenomas].
Rozsíval V; Látr I; Golda V; Cerman J
Cas Lek Cesk; 1983 Jan; 122(4):118-20. PubMed ID: 6825151
[No Abstract] [Full Text] [Related]
7. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.
Colao A; Ferone D; Lastoria S; Cerbone G; Di Sarno A; Di Somma C; Lucci R; Lombardi G
Clin Endocrinol (Oxf); 2000 Apr; 52(4):437-45. PubMed ID: 10762286
[TBL] [Abstract][Full Text] [Related]
8. Bromocriptine treatment of women with suspected pituitary prolactin-secreting microadenomas.
Archer DF; Lattanzi DR; Moore EE; Harger JH; Herbert DL
Am J Obstet Gynecol; 1982 Jul; 143(6):620-5. PubMed ID: 7201244
[TBL] [Abstract][Full Text] [Related]
9. Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography.
Johnston DG; Hall K; Kendall-Taylor P; Patrick D; Watson M; Cook DB
Lancet; 1984 Jul; 2(8396):187-92. PubMed ID: 6146751
[TBL] [Abstract][Full Text] [Related]
10. [Lisurid in the treatment of hyperprolactinemia: comments on the article by J. Presl].
Pospísil O
Cesk Gynekol; 1980 Nov; 45(9):679-81. PubMed ID: 7197199
[No Abstract] [Full Text] [Related]
11. Psychotic reactions during treatment of pituitary tumours with dopamine agonists.
Turner TH; Cookson JC; Wass JA; Drury PL; Price PA; Besser GM
Br Med J (Clin Res Ed); 1984 Oct; 289(6452):1101-3. PubMed ID: 6435792
[TBL] [Abstract][Full Text] [Related]
12. Size reduction of macroprolactinomas by bromocriptine or lisuride treatment.
Chiodini P; Liuzzi A; Cozzi R; Verde G; Oppizzi G; Dallabonzana D; Spelta B; Silvestrini F; Borghi G; Luccarelli G; Rainer E; Horowski R
J Clin Endocrinol Metab; 1981 Oct; 53(4):737-43. PubMed ID: 7287863
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural morphometry of prolactin secreting adenomas treated with dopamine agonists.
Schottke H; Saeger W; Lüdecke DK; Caselitz J
Pathol Res Pract; 1986 Jun; 181(3):280-90. PubMed ID: 3748874
[TBL] [Abstract][Full Text] [Related]
14. Medical treatment of pituitary adenomas: effects on tumor growth.
Liuzzi A; Chiodini PG; Dallabonzana D; Oppizzi G; Verde GG
J Endocrinol Invest; 1985 Jun; 8(3):273-81. PubMed ID: 2863300
[No Abstract] [Full Text] [Related]
15. Prolactin-secreting pituitary microadenomas.
Vezina JL; Sutton TJ; Maltais R; Hardy J
Acta Radiol Suppl; 1976; 347():561-6. PubMed ID: 207147
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of cabergoline in reducing follicle-stimulating hormone and prolactin hypersecretion from pituitary macroadenoma in an infertile woman.
Paoletti AM; Depau GF; Mais V; Guerriero S; Ajossa S; Melis GB
Fertil Steril; 1994 Oct; 62(4):882-5. PubMed ID: 7926104
[TBL] [Abstract][Full Text] [Related]
17. Size changes of a growth hormone- and prolactin-producing adenoma during and after sandostatin treatment.
García-Luna PP; Leal del Cerro A; Santos C; Montero C; Acosta D; Navarro E; del Pozo E; Gómez-Pan A; Astorga R
Horm Res; 1988; 29(2-3):109-11. PubMed ID: 2900188
[TBL] [Abstract][Full Text] [Related]
18. Prolactin-producing pituitary tumors: radiologic diagnosis.
Baylin GJ; Pipkin IH
Clin Obstet Gynecol; 1980 Jun; 23(2):385-401. PubMed ID: 7398156
[No Abstract] [Full Text] [Related]
19. Shrinkage of a PRL-secreting pituitary macroadenoma resistant to cabergoline.
Cannavò S; Bartolone L; Blandino A; Spinella S; Galatioto S; Trimarchi F
J Endocrinol Invest; 1999 Apr; 22(4):306-9. PubMed ID: 10342366
[TBL] [Abstract][Full Text] [Related]
20. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
Bergström M; Muhr C; Lundberg PO; Bergström K; Gee AD; Fasth KJ; Långström B
J Comput Assist Tomogr; 1987; 11(5):815-9. PubMed ID: 3498743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
